These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 17456483

  • 1. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
    Belardinelli R, Solenghi M, Volpe L, Purcaro A.
    Eur Heart J; 2007 May; 28(9):1102-8. PubMed ID: 17456483
    [Abstract] [Full Text] [Related]

  • 2. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 3. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S, Gielen S, Linke A, Möbius-Winkler S, Adams V, Baither Y, Schuler G, Hambrecht R.
    Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
    [Abstract] [Full Text] [Related]

  • 4. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E, Ozdemir R, Barutcu I, Aksoy Y, Sincer I, Akturk E, Cehreli S.
    J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
    [Abstract] [Full Text] [Related]

  • 5. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 6. Effects of trimetazidine on endothelial dysfunction after sheath injury of radial artery.
    Park KH, Park WJ, Kim MK, Park DW, Park JH, Kim HS, Cho GY.
    Am J Cardiol; 2010 Jun 15; 105(12):1723-7. PubMed ID: 20538121
    [Abstract] [Full Text] [Related]

  • 7. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
    Ma QL, Xie Y, Zhang SD.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):527-9. PubMed ID: 12658930
    [Abstract] [Full Text] [Related]

  • 8. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 28; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep 28; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 10. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 28; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 11. Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
    Cera M, Salerno A, Fragasso G, Montanaro C, Gardini C, Marinosci G, Arioli F, Spoladore R, Facchini A, Godino C, Margonato A.
    J Cardiovasc Pharmacol Ther; 2010 Mar 28; 15(1):24-30. PubMed ID: 20100903
    [Abstract] [Full Text] [Related]

  • 12. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study.
    Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP.
    Eur Heart J; 2007 Sep 28; 28(18):2249-55. PubMed ID: 17644511
    [Abstract] [Full Text] [Related]

  • 13. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, Juhani Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J.
    Circulation; 2008 Sep 16; 118(12):1250-8. PubMed ID: 18765391
    [Abstract] [Full Text] [Related]

  • 14. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.
    Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770
    [Abstract] [Full Text] [Related]

  • 15. The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease.
    Aygen B, Celiker H, Dogukan A, Ilhan N.
    Methods Find Exp Clin Pharmacol; 2008 Dec 09; 30(10):757-60. PubMed ID: 19271025
    [Abstract] [Full Text] [Related]

  • 16. Effects of sheath injury and trimetazidine on endothelial dysfunction of radial artery after transradial catheterization.
    Park KH, Park DW, Kim MK, Kim HS, Park WJ, Cho GY, Choi YJ.
    J Interv Cardiol; 2012 Aug 09; 25(4):411-7. PubMed ID: 22536918
    [Abstract] [Full Text] [Related]

  • 17. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK.
    Klin Med (Mosk); 2004 Aug 09; 82(11):15-20. PubMed ID: 15656392
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats.
    Yoon JW, Cho BJ, Park HS, Kang SM, Choi SH, Jang HC, Shin H, Lee MJ, Kim YB, Park KS, Lim S.
    Int J Cardiol; 2013 Jul 15; 167(1):126-33. PubMed ID: 22240760
    [Abstract] [Full Text] [Related]

  • 19. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 15; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 20. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
    Zhang L, Lu Y, Jiang H, Zhang L, Sun A, Zou Y, Ge J.
    J Am Coll Cardiol; 2012 Mar 06; 59(10):913-22. PubMed ID: 22381427
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.